CD34 and myelodysplastic syndrome: BMB from controls and MDS/sAML patients exhibited only minor differences regarding the frequencies of respective immune cell subsets within the BM (Figure 3A), but demonstrated major differences in the spatial distribution of the immune cell subsets and the CD34+ HSPC/blasts, respectively (Figure 3B,C).